Zentalis Pharmaceuticals Files 8-K on Shareholder Vote Matters
Ticker: ZNTL · Form: 8-K · Filed: Jun 18, 2025 · CIK: 1725160
Sentiment: neutral
Topics: governance, shareholder-vote
TL;DR
Zentalis held a shareholder vote on June 17th. Details filed today.
AI Summary
Zentalis Pharmaceuticals, Inc. filed an 8-K on June 18, 2025, reporting on matters submitted to a vote of security holders on June 17, 2025. The filing details the company's corporate actions and governance, as is standard for this type of report.
Why It Matters
This filing indicates that Zentalis Pharmaceuticals held a shareholder vote, which is a key governance event that can impact corporate direction and shareholder rights.
Risk Assessment
Risk Level: low — This is a routine 8-K filing regarding a shareholder vote, which typically does not involve new material financial or operational information.
Key Players & Entities
- Zentalis Pharmaceuticals, Inc. (company) — Registrant
- June 17, 2025 (date) — Date of earliest event reported
- June 18, 2025 (date) — Date of report
FAQ
What specific matters were submitted to a vote of Zentalis Pharmaceuticals' security holders on June 17, 2025?
The filing states that the report concerns 'Submission of Matters to a Vote of Security Holders' but does not specify the exact proposals voted upon in the provided text.
What is the SEC file number for Zentalis Pharmaceuticals?
The SEC file number for Zentalis Pharmaceuticals is 001-39263.
When was Zentalis Pharmaceuticals, Inc. incorporated?
The filing indicates the state of incorporation is Delaware.
What is the primary business of Zentalis Pharmaceuticals?
Zentalis Pharmaceuticals is in the 'PHARMACEUTICAL PREPARATIONS' industry, SIC code 2834.
What is the fiscal year end for Zentalis Pharmaceuticals?
The fiscal year end for Zentalis Pharmaceuticals is December 31.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 18, 2025 regarding Zentalis Pharmaceuticals, Inc. (ZNTL).